The charity event, organized by the Biotechnology Business Institute in collaboration with the Richi Childhood Cancer Foundation, raised money from the attendees to boost innovative companies researching in pediatric oncology.

The Biotechnology Business Institute, in the frame of its fifth anniversary, celebrated the first Summer Charity Cocktail, together with the Richi Childhood Cancer Foundation, as part of its commitment with the development of Life Sciences. The venue gathered together more than 100 people to present the first annual Childhood Cancer Innovation Award, an initiative from both centers to support international expansion in the Biotechnology sector.

As part of its fifth anniversary, the Institute also took the opportunity to celebrate with the students the end of the masters and postgraduate courses of the current academic year. These students have been the first to take part in the Discover and Transfer educational program created by the Biotechnology Business Institute.

The Chairman of the Institute, Juan R. García, and the Managing Director, Natalia Oñate, invited the entire BBI community, among with relatives, friends, colleagues, alumni and international professionals from Biotechnology sector and Pharmaceutical industry. The evening was also the moment to celebrate the establishment of the Institute as an educational center of reference in Barcelona in the formation of scientific profiles in Healthcare industry and entrepreneurship in Life Sciences.

This collaboration with Richi Entrepreneurs and its Boston Inmersion Program aims to go beyond the Institute’s values and mission. With the implementation of this annual award, the business school will be focused not only on the training of leaders in Pharma & Biotech, but also helping international entrepreneurship and the development of innovative ideas.

The winning startup will travel to the city of Boston and will have the opportunity to continue with the development of their projects and be part of one of the best Healthcare ecosystem of the world. The three pre-selected companies, Iproteos, BIOGENERA SpA and PARPiPRED project (VHIO), made a short presentation of their main projects in the field of childhood oncology and the reasons that led them to research in this disease.


That night, the Italian BIOGENERA SpA was the winner of the first edition of the award. Thanks to the participation of the attendees and sponsors, the other two finalists will receive hours of business development consulting, while the winner team will participate next October in the Boston Immersion Program, along with other young international companies that present innovative solutions to fight childhood cancer.

At the end of the event, the Biotechnology Business Institute and the Richi Childhood Cancer Foundation wanted to thank the sponsorship of Alira Health and everyone who attended the Summer Charity Cocktail for its collaboration and involvement with childhood cancer as well as their interest in being part of the BBI community and celebrating the business school's fifth anniversary.


Click here to see the photos of the first Summer Charity Cocktail

Latest news

The Biotechnology Business Institute closes the 5th edition of the Scientific MBA in Lifesciences with a great success and four projects developing drug candidates.

Four drug candidates targeting three indications, Breast Cancer, Chron’s Syndrome and NASH (nonalcoholic steatohepatitis), were presented by our students in the closing ceremony of the Scientific MBA’s as a result of a year developing different intellectual properties for potential new treatments

BBI Case Study in International Strategy. Aortyx, a success case in early stage funding for medical device focus in aortic disease

During the evening of the BBI Open Day a study case in early stage funding was presented by Jordi Martorell, Patrick O’Brien, Lifesciences consultant, and William Hariri, Director at Alira Health. The main objective of the evening was to understand how to develop and international strategy for medical devices.

The Biotechnology Business Institute closes the first BBI Open Day with great success inspiring young scientific professionals

The importance of scientific profiles in a society based in innovation and how their professional development in management can contribute to drug discovery, were some of the main topics presented during the BBI Open Day 2019

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

Filter by category